Viral and Antiviral Nanomaterials

Viral and Antiviral Nanomaterials

Synthesis, Properties, Characterization, and Application

Islam, Saher; Thangadurai, Devarajan; Oluwaseun Adetunji, Charles

Taylor & Francis Ltd






15 a 20 dias


Descrição não disponível.
Section I: Nanosized Materials in Virology 1. Viruses as Nanomaterials 2. Synthesis and Characterization of Nanoparticles as Potential Viral and Antiviral Agents 3. Biogenic Synthesis of Nanoparticulate Materials for Antiviral Applications 4. Nanoparticle Synthesis and Administration Routes for Antiviral Uses 5. Role of Nanostructures in Inhibition and Treatment of Viral Infections Section II: Viral Nanomaterials: Biomedical Applications 6. Photocatalytic Inactivation of Pathogenic Viruses Using Metal Oxide and Carbon-Based Nanoparticles 7. Non-Photocatalytic and Photocatalytic Inactivation of Viruses Using Antiviral Assays and Antiviral Nanomaterials 8. Application of Viral Nanomaterials in Medicine 9. Virus-Based Nanocarriers for Targeted Drug Delivery Section III: Antiviral Nanotherapeutics 10. Antiviral Nanomaterials in Therapeutic Interventions 11. In Vivo Study of Anti-In?uenza Effect of Silver Nanoparticles in a Mouse Model 12. Antiviral Drugs as Tools for Nanomedicine 13. Emerging Nanotechnology-Enabled Approaches to Mitigate COVID-19 Pandemic 14. Applications of Antiviral Nanoparticles in Cancer Therapy 15. Nano Delivery of Antiviral Plant Bioactives as Cancer Therapeutics 16. Conjugated Graphene Gold Nanocomposites for Cancer Therapy 17. Surface Engineered Graphene Oxide and Its Derivatives: A Prospective Nano-Structured Carbon as Anticancer Agent 18. Antiviral Nanomaterials as Potential Targets for Malaria Prevention and Treatment
viral diseases;viral nanotechnology;Covid-19;antiviral;nanodrugs;MERS;Microbial infections;CCMV.;Influenza Virus;CPMV.;HBV.;Graphene Oxide;Viral Nanoparticles;PRRSV.;PEDV;SLNs;Nano Drug Delivery Systems;MS2 Virus;MERS CoV;Photocatalytic Inactivation;Nano Carrier System;BMV;Au Nano Rods;Ag NPs;Antiviral Candidates;PRRSV Infection;Plant Bioactives;Ct DNA;Transdermal Drug Delivery;NLC;Envelop RNA Virus